A 57 year old female presented with an amyloid myopathy in association with lambda light chain myeloma. Treatment with melphalan and prednisolone resulted in remission of both myeloma and myopathy.
Introduction
Both primary and secondary amyloidosis are uncommon disorders. Monoclonal immunoproteins, particularly light-chains, can be demonstrated in a majority ofpatients with primary amyloidosis.' Frank myeloma is present less frequently. The incidence of amyloidosis in patients with myeloma is 6-15%.2 The prognosis of primary amyloidosis is poor (median survival 4.9-14.7 months from diagnosis).2 It is worse when myeloma is present (median survival [4] [5] Patchy distribution of amyloid can occur and this may have an effect on histological comparisons of biopsy specimens. Notwithstanding this, we believe that our patient showed good clinical and histological evidence of regression of amyloid deposits. The clinical improvement was maintained for 4 years.
Primary amyloidosis is an uncommon disorder with a poor prognosis, particularly if myeloma is present. This case report demonstrates that occasional patients respond to melphalan and prednisolone. An attempt at treatment with these drugs is therefore justified. 
